An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Vaxxinova US, Inc. in Willmar, Minnesota, is seeking an Accountant to support our finance team with accurate financial processing, reporting and compliance activities.
The role collaborates across departments on month-end close, reconciliations, budgeting and internal controls, using GAAP and IFRS guidelines and strong Excel skills. Three to five years of accounting experience is preferred; we offer competitive pay and benefits and opportunities for growth within a collaborative, supportive
If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.
Willmar, MN, US
9 days ago Requisition ID: 1194
Salary Range: $28.00 To $38.00 Hourly
Vaxxinova US is seeking an individual to join our finance team as an Accountant in Willmar, Minnesota.
At Vaxxinova US, you’ll be part of a passionate team dedicated to making a difference. We offer competitive pay and benefits, opportunities for growth, and a supportive work culture.
The Accountant is responsible for supporting the company’s accounting and financial operations through accurate financial processing, reporting, analysis, and compliance activities. This position works collaboratively across departments to ensure timely and reliable financial information while supporting operational and business objectives.
We are proud to offer a generous benefit package in addition to competitive compensation, including employer contributions towards medical, dental and vision premiums. Most benefits begin on date of hire. Our benefits include:
Vaxxinova provides a wide range of both autogenous and licensed vaccines combined with high-level diagnostic services, supported by strong R&D. Our focus is on livestock including cattle, poultry, swine and aqua. Vaxxinova US, formerly known as Epitopix and Newport Laboratories, is the US operating unit of Vaxxinova International, headquartered in the Netherlands. Vaxxinova US has a strong market presence making autogenous vaccines for cattle, swine, and poultry as well as a state‑of‑the‑art diagnostic laboratory. Vaxxinova currently has facilities in fourteen countries including Brazil, Canada, Chile, Colombia, Croatia, Italy, Germany, Japan, Jordan, Norway, South Africa, Thailand, the USA, and the Netherlands. Vaxxinova is part of the family‑owned EW Group, headquartered in Germany. The EW Group specializes in animal genetics, animal nutrition and animal health, operates in over 100 countries and records consistent international growth.